Cargando…
Another trial for the TARGET trial. Author’s reply
Autores principales: | Hagel, Stefan, Pletz, Mathias W., Lehmann, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205821/ https://www.ncbi.nlm.nih.gov/pubmed/35320369 http://dx.doi.org/10.1007/s00134-022-06670-9 |
Ejemplares similares
-
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author’s reply
por: Hagel, Stefan, et al.
Publicado: (2022) -
Surrogate end points and their role in clinical trials: Reply from authors
por: Kalikar, M.V., et al.
Publicado: (2009) -
The Author Replies
por: Ferenci, Tamás
Publicado: (2022) -
Author's reply
por: Lagunes-Cordoba, Emmeline
Publicado: (2022) -
Authors' Reply
por: Tian, Di, et al.
Publicado: (2022)